Free catecholamine excretion in the urine in normal infants and in those with marasmus or kwashiorkor

Insights

Free catecholamine excretion in infants with malnutrition was similar to healthy infants, except in cases of severe infection. Rehabilitation normalized catecholamine levels in marasmic infants.

Area of Science:

  • Pediatric Endocrinology
  • Nutritional Science
  • Biochemistry

Background:

  • Free catecholamine (epinephrine + norepinephrine) levels are crucial indicators of physiological stress and metabolic status in infants.
  • Malnutrition, such as marasmus and marasmic kwashiorkor, significantly impacts infant physiology and stress responses.
  • Understanding catecholamine excretion patterns in malnourished infants is vital for assessing their health and response to treatment.

Purpose of the Study:

  • To measure and compare free catecholamine (epinephrine + norepinephrine) excretions in normal male infants and infants with marasmus or marasmic kwashiorkor.
  • To assess the impact of partial rehabilitation on catecholamine excretion in malnourished infants.
  • To investigate age-related differences and the influence of infection on catecholamine levels.

Main Methods:

  • Collected 24-hour urine samples over three consecutive days from normal infants (2.1-18.5 months) and malnourished infants (marasmus, marasmic kwashiorkor) upon admission and after partial rehabilitation.
  • Measured free catecholamine (epinephrine + norepinephrine) concentrations using biochemical assays.
  • Normalized catecholamine excretion to body surface area (mug/m-2/day) for age-group comparisons.

Main Results:

  • Normal infants showed increased catecholamine excretion with age, but not significantly when adjusted for surface area.
  • Marasmic infants' admission catecholamine excretions were similar to controls, with higher values in those with severe infection.
  • Marasmic infants' excretions normalized after partial rehabilitation; marasmic kwashiorkor infants showed no difference from controls unless severely infected.

Conclusions:

  • Free catecholamine excretion is not significantly different in infants with marasmus or marasmic kwashiorkor compared to healthy infants, except in cases of severe infection.
  • Partial rehabilitation effectively normalized catecholamine excretion in marasmic infants.
  • Day-to-day variation in catecholamine excretion was more pronounced at admission in malnourished infants, particularly those with severe infections.

Related Concept Videos

Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...